Ephrine Plus Tablet (Caffeine 200 mg, Vitamin C 25 mg) Supplement, ULTRAtab Laboratories, Inc.,…
Recalling firm: ULTRAtab Laboratories, Inc.
cGMP Deviations
Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Sep 1, 2022.
Check your package
Compare the exact product and package details with the label you have.
FDA code information
Product Codes: M943 M943L Bulk Lots: 16K038, 18B075
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
Ephrine Plus Tablet (Caffeine 200 mg, Vitamin C 25 mg) Supplement, ULTRAtab Laboratories, Inc., Highland, NY
Original FDA recall reason
cGMP Deviations
Recall details
- Recall number
- F-0721-2022
- Event ID
- 89512
- FDA status
- Terminated
- Initiated
- Oct 6, 2021
- Reported
- Feb 16, 2022
- Classified
- Feb 9, 2022
- Terminated
- Sep 1, 2022
- Quantity
- 4,250,842 tablets
- Location
- Highland, NY, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Letter
Where it was distributed
Bulk product was distributed to 2 distributors (NY, FL) who may have repackaged the product and further distributed finished product.
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.